Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleni Korompoki

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
International Journal of Stroke : Official Journal of the International Stroke Society|May 20, 2020
Identification of patients with embolic stroke of undetermined source and low risk of new incident atrial fibrillation: The AF-ESUS scoreGeorge Ntaios, Kalliopi Perlepe, Dimitris Lambrou, et al.
Stroke|April 17, 2020
Potential Embolic Sources and Outcomes in Embolic Stroke of Undetermined Source in the NAVIGATE-ESUS TrialGeorge Ntaios, Lesly A Pearce, Roland Veltkamp, et al.
European Journal of Neurology|July 5, 2021
COVID-19 and ischemic strokeDimitrios Sagris, Aikaterini Papanikolaou, Alexandra Kvernland, et al.
The Journal of Infection|May 16, 2021
Epidemiology and organ specific sequelae of post-acute COVID19: A narrative reviewEleni Korompoki, Maria Gavriatopoulou, Rachel S Hicklen, et al.
Cells|August 27, 2021
Kinetics of Anti-SARS-CoV-2 Antibody Responses 3 Months Post Complete Vaccination with BNT162b2; A Prospective Study in 283 Health WorkersEvangelos Terpos, Ioannis P Trougakos, Vangelis Karalis, et al.
Frontiers in Immunology|December 13, 2021
Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 InfectionMargherita Rosati, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, et al.
Hemasphere|December 23, 2021
Sustained but Declining Humoral Immunity Against SARS-CoV-2 at 9 Months Postvaccination With BNT162b2: A Prospective Evaluation in 309 Healthy IndividualsEvangelos Terpos, Vangelis Karalis, Ioannis Ntanasis-Stathopoulos, et al.
Microorganisms|April 3, 2021
Recovery of Innate Immune Cells and Persisting Alterations in Adaptive Immunity in the Peripheral Blood of Convalescent Plasma Donors at Eight Months Post SARS-CoV-2 InfectionIoannis V Kostopoulos, Nikolaos Orologas-Stavrou, Pantelis Rousakis, et al.
Vaccines|October 26, 2021
Nocebo-Prone Behavior Associated with SARS-CoV-2 Vaccine Hesitancy in Healthcare WorkersDimos D Mitsikostas, Konstantina Aravantinou-Fatorou, Christina Deligianni, et al.
BMC Medicine|August 23, 2021
Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patientsIoannis P Trougakos, Evangelos Terpos, Christina Zirou, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
International Journal of Stroke : Official Journal of the International Stroke Society|May 20, 2020
Identification of patients with embolic stroke of undetermined source and low risk of new incident atrial fibrillation: The AF-ESUS scoreGeorge Ntaios, Kalliopi Perlepe, Dimitris Lambrou, et al.
Stroke|April 17, 2020
Potential Embolic Sources and Outcomes in Embolic Stroke of Undetermined Source in the NAVIGATE-ESUS TrialGeorge Ntaios, Lesly A Pearce, Roland Veltkamp, et al.
European Journal of Neurology|July 5, 2021
COVID-19 and ischemic strokeDimitrios Sagris, Aikaterini Papanikolaou, Alexandra Kvernland, et al.
The Journal of Infection|May 16, 2021
Epidemiology and organ specific sequelae of post-acute COVID19: A narrative reviewEleni Korompoki, Maria Gavriatopoulou, Rachel S Hicklen, et al.
Cells|August 27, 2021
Kinetics of Anti-SARS-CoV-2 Antibody Responses 3 Months Post Complete Vaccination with BNT162b2; A Prospective Study in 283 Health WorkersEvangelos Terpos, Ioannis P Trougakos, Vangelis Karalis, et al.
Frontiers in Immunology|December 13, 2021
Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 InfectionMargherita Rosati, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, et al.
Hemasphere|December 23, 2021
Sustained but Declining Humoral Immunity Against SARS-CoV-2 at 9 Months Postvaccination With BNT162b2: A Prospective Evaluation in 309 Healthy IndividualsEvangelos Terpos, Vangelis Karalis, Ioannis Ntanasis-Stathopoulos, et al.
Microorganisms|April 3, 2021
Recovery of Innate Immune Cells and Persisting Alterations in Adaptive Immunity in the Peripheral Blood of Convalescent Plasma Donors at Eight Months Post SARS-CoV-2 InfectionIoannis V Kostopoulos, Nikolaos Orologas-Stavrou, Pantelis Rousakis, et al.
Vaccines|October 26, 2021
Nocebo-Prone Behavior Associated with SARS-CoV-2 Vaccine Hesitancy in Healthcare WorkersDimos D Mitsikostas, Konstantina Aravantinou-Fatorou, Christina Deligianni, et al.
BMC Medicine|August 23, 2021
Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patientsIoannis P Trougakos, Evangelos Terpos, Christina Zirou, et al.
Pageof 10